Jeff Monat

Mr. Monat has been investing in cannabis since 2013, starting with an investment in Theraplant, where he originally backed Mitch Baruchowitz's licensing efforts. He has been an investment professional for over 15 years, beginning his career in the Mergers and Acquisitions department of Goldman Sachs. He then worked in the Goldman Sachs Principal Strategies Group, analyzing public-market opportunities for the firm's proprietary investment fund. Since Goldman, Mr. Monat served in an analyst role at Rockbay Capital, where he was a partner that helped grow the firm to $1 billion in AUM, and FrontPoint Rockbay, an event-driven hedge fund in New York. He served as a Senior Analyst at Seven Locks Capital, a long/short equity hedge fund and was a Senior Analyst at Sage Rock Capital, an event-driven hedge fund based in New York. Mr. Monat has a Bachelor of Science in Economics from The Wharton School of the University of Pennsylvania.